e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
COPD: diagnosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling
N. Fens, A. G. J. van Rossum, P. Zanen, B. van Ginneken, R. J. van Klaveren, A. H. Zwinderman, P. J. Sterk (Amsterdam, Utrecht, Rotterdam, Netherlands)
Source:
Annual Congress 2010 - COPD: diagnosis
Session:
COPD: diagnosis
Session type:
Thematic Poster Session
Number:
4020
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Fens, A. G. J. van Rossum, P. Zanen, B. van Ginneken, R. J. van Klaveren, A. H. Zwinderman, P. J. Sterk (Amsterdam, Utrecht, Rotterdam, Netherlands). Identification of COPD phenotypes using cluster analysis including exhaled air molecular profiling. Eur Respir J 2010; 36: Suppl. 54, 4020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Identification of asthma phenotypes using cluster analysis
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Sputum transcriptomic analysis of air pollutant signatures: link to asthma severity and phenotype
Source: Virtual Congress 2021 – Environment and air pollution
Year: 2021
External validation of exhaled breath molecular profiling in identifying COPD and asthma
Source: Annual Congress 2010 - Biomarkers of asthma and COPD: recent advances
Year: 2010
Exhaled breath molecular profiling in measuring inflammatory status in COPD
Source: Annual Congress 2008 - Inflammatory biomarkers
Year: 2008
Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Early detection of lung cancer through analysis of VOC biomarkers in exhaled breath: The LuCID study.
Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies
Year: 2017
Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate
Source: International Congress 2017 – Clinical problems in lung diseases
Year: 2017
Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath
Source: ERS Lung Science Conference 2016
Year: 2016
Real-time exhaled breath analysis identifies altered metabolic signature in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Use of cluster analysis to define COPD phenotypes
Source: Eur Respir J 2010; 36: 472-474
Year: 2010
Exclusion of asthma for screening purposes using exhaled air molecular profiling by electronic nose
Source: Annual Congress 2011 - Respiratory epidemiology: methods, definitions and phenotypes
Year: 2011
Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: Suppl. 50, 747s
Year: 2006
Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
Identification of COPD phenotypes using factor analysis
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept